Α -bisabolol mitigates colon inflammation by stimulating colon ppar- γ transcription factor: in vivo and in vitro study

HIGHLIGHTS

• who: Balaji Venkataraman and collaborators from the Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Box-17666, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA have published the paper: u03b1 -Bisabolol Mitigates Colon Inflammation by Stimulating Colon PPAR- u03b3 Transcription Factor: In Vivo and In Vitro Study, in the Journal: PPAR Research of 13/04/2022
• what: The initial experiments were designed to investigate the effect of various concentrations of u03b1-bisabolol(0-200 u03bcM for 24 h) on HT-29 cell viability. The studies have confirmed that u03b1 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.